# Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer

> **NCT06160323** · NA · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 94 (estimated)

## Conditions studied

- Pancreatic Cancer Non-resectable
- Tumor Pancreas
- Pain Cancer

## Interventions

- **PROCEDURE:** EUS-guided coeliac ganglion neurolysis / celiac plexus neurolysis

## Key facts

- **NCT ID:** NCT06160323
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-10
- **Primary completion:** 2027-07-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06160323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06160323, "Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06160323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*